Showing 1 - 12 results of 12 for search 'Mingye Zhao', query time: 0.04s Refine Results
  1. 1
    Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysis

    Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysi... by Xi Chen, Xi Chen, Mingye Zhao, Mingye Zhao, Lei Tian, Lei Tian

    Published 2023-03-01
    Get full text
    Article
  2. 2
    Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-small cell lung cancer: A sequential model

    Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-sma... by Mingye Zhao, Mingye Zhao, Taihang Shao, Taihang Shao, Zhuoyuan Chi, Zhuoyuan Chi, Wenxi Tang, Wenxi Tang

    Published 2023-02-01
    Get full text
    Article
  3. 3
    Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis

    Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis by Yunlin Jiang, Mingye Zhao, Wenxi Tang, Xueping Zheng

    Published 2024-02-01
    Get full text
    Article
  4. 4
    Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis

    Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analy... by Mingye Zhao, Taihang Shao, Hanqiao Shao, Caicun Zhou, Wenxi Tang

    Published 2024-02-01
    Get full text
    Article
  5. 5
    Comparison of systemic treatments for previously treated patients with unresectable colorectal liver metastases: a systematic review and network meta-analysis

    Comparison of systemic treatments for previously treated patients with unresectable colorectal liver metastases: a systematic review and network meta-analysis by Yunlin Jiang, Yunlin Jiang, Mingye Zhao, Wenxi Tang, Xueping Zheng

    Published 2024-07-01
    Get full text
    Article
  6. 6
    Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China

    Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China by Leyi Liang, Taihang Shao, Hao Li, Mingye Zhao, Wenxi Tang

    Published 2023-08-01
    Get full text
    Article
  7. 7
    A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases

    A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases by Yunlin Jiang, Yunlin Jiang, Taihang Shao, Mingye Zhao, Yahong Xue, Xueping Zheng

    Published 2024-07-01
    Get full text
    Article
  8. 8
    Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective

    Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective by Hanqiao Shao, Hongshu Fang, Yuan Li, Yunlin Jiang, Mingye Zhao, Wenxi Tang

    Published 2024-09-01
    Get full text
    Article
  9. 9
    Hypoxemia in thoracoscopic lung resection surgery using a video double-lumen tube versus a conventional double-lumen tube: A propensity score-matched analysis

    Hypoxemia in thoracoscopic lung resection surgery using a video double-lumen tube versus a conventional double-lumen tube: A propensity score-matched analysis by Wei Wang, Zhihao Gong, Mingye Zhao, Zuojing Zhang, Yuwei Qiu, Qiliang Jiang, Jingxiang Wu

    Published 2023-02-01
    Get full text
    Article
  10. 10
    Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: a United Kingdom health care perspective

    Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: a United Kingdom health care pe... by Yunlin Jiang, Yunlin Jiang, Mingye Zhao, Jiayi Xi, Jiaqi Li, Wenxi Tang, Xueping Zheng

    Published 2023-09-01
    Get full text
    Article
  11. 11
    A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancer

    A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced brea... by Hanqiao Shao, Mingye Zhao, Ai-Jia Guan, Taihang Shao, Dachuang Zhou, Guo Yu, Wenxi Tang

    Published 2024-01-01
    Get full text
    Article
  12. 12
    Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method

    Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method by Qian Peng, Yue Yin, Min Liang, Mingye Zhao, Taihang Shao, Yaqian Tang, Zhiqing Mei, Hao Li, Wenxi Tang

    Published 2023-11-01
    Get full text
    Article

Search Tools: